{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:44:38Z","timestamp":1788799478472,"version":"build-2803163510"},"reference-count":20,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>Abstract is missing (Short communication)<\/jats:p>","DOI":"10.2340\/actadv.v104.41982","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T05:55:17Z","timestamp":1730872517000},"page":"adv41982","source":"Crossref","is-referenced-by-count":2,"title":["Brentuximab Vedotin-induced Tumour Lysis Syndrome in Mycosis Fungoides: A Case Report"],"prefix":"10.2340","volume":"104","author":[{"given":"Berenika","family":"Olszewska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Zarycza\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman J.","family":"Nowicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Soko\u0142owska-Wojdy\u0142o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"83516","unstructured":"Adeyinka A, Bashir K. Tumor lysis syndrome. 2022 Oct 31. In: StatPearls (Internet). Treasure Island (FL): StatPearls Publishing; 2024."},{"key":"83517","doi-asserted-by":"crossref","unstructured":"Cairo MS, Coiffier B, Reiter A, Younes A; TLS Expert Panel. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br J Haematol 2010; 149: 578-586.","DOI":"10.1111\/j.1365-2141.2010.08143.x"},{"key":"83518","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/j.1365-2141.2010.08143.x","DOI":"10.1111\/j.1365-2141.2010.08143.x"},{"key":"83519","doi-asserted-by":"crossref","unstructured":"Sury K. Update on the prevention and treatment of tumor lysis syndrome. J Onco Nephrol 2019; 3: 19-30.","DOI":"10.1177\/2399369319837212"},{"key":"83520","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1177\/2399369319837212","DOI":"10.1177\/2399369319837212"},{"key":"83521","doi-asserted-by":"crossref","unstructured":"Howard SC, Trifilio S, Gregory TK, Baxter N, McBride A. Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review. Ann Hematol 2016; 95: 563-573.","DOI":"10.1007\/s00277-015-2585-7"},{"key":"83522","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s00277-015-2585-7","DOI":"10.1007\/s00277-015-2585-7"},{"key":"83523","doi-asserted-by":"crossref","unstructured":"Pro B, Advani R, Brice P, Bartlett NL, Rosenblatt JD, Illidge T et al. Brentuximab vedotin (SGN- 35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study. J Clin Oncol 2012; 30: 2190-2196.","DOI":"10.1200\/JCO.2011.38.0402"},{"key":"83524","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1200\/JCO.2011.38.0402","DOI":"10.1200\/JCO.2011.38.0402"},{"key":"83525","doi-asserted-by":"crossref","unstructured":"Abdelmouttalib A, Elghtaibi FZ, Sialiti S, Senouci, K. S\u00e9zary syndrome preceded by mycosis fungoides and complicated by tumor lysis syndrome and macrophage activation syndrome. Our Dermatol Online 2022; 13: 114-115.","DOI":"10.7241\/ourd.20221.32"},{"key":"83526","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.7241\/ourd.20221.32","DOI":"10.7241\/ourd.20221.32"},{"key":"83527","doi-asserted-by":"crossref","unstructured":"Kopterides P, Lignos M, Mavrou I, Armaganidis A. Steroid- induced tumor lysis syndrome in a patient with mycosis fungoides treated for presumed pneumocystis carinii pneumonia. Am J Hematol 2005; 80: 309.","DOI":"10.1002\/ajh.20444"},{"key":"83528","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/ajh.20444","DOI":"10.1002\/ajh.20444"},{"key":"83529","unstructured":"Brentuximab vedotin (Adcteris). European Medicines Agency (EMA) [accessed October 16, 2016]. Available from: https:\/\/www.ema.europa.eu"},{"key":"83530","doi-asserted-by":"crossref","unstructured":"Wilson FP, Berns JS. Tumor lysis syndrome: new challenges and recent advances. Adv Chronic Kidney Dis 2014; 21: 18-26.","DOI":"10.1053\/j.ackd.2013.07.001"},{"key":"83531","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1053\/j.ackd.2013.07.001","DOI":"10.1053\/j.ackd.2013.07.001"},{"key":"83532","doi-asserted-by":"crossref","unstructured":"Stephanos K, Picard L. Pediatric oncologic emergencies. Emerg Med Clin North Am 2018; 36: 527-535.","DOI":"10.1016\/j.emc.2018.04.007"},{"key":"83533","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.emc.2018.04.007","DOI":"10.1016\/j.emc.2018.04.007"},{"key":"83534","doi-asserted-by":"crossref","unstructured":"Darmon M, Guichard I, Vincent F, Schlemmer B, Azoulay E. Prognostic significance of acute renal injury in acute tumor lysis syndrome. Leuk Lymphoma. 2010; 51: 221-227.","DOI":"10.3109\/10428190903456959"},{"key":"83535","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3109\/10428190903456959","DOI":"10.3109\/10428190903456959"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/41982\/48114","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/41982\/48114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T05:55:26Z","timestamp":1730872526000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/41982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":20,"URL":"https:\/\/doi.org\/10.2340\/actadv.v104.41982","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,5]]}}}